Daniel McGuire
General Counsel
Replay available
Vanda Pharmaceuticals Inc. (VNDA) Q2 2026 Earnings Call
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Kevin Moran
Chief Financial Officer
Dr. Mihael Polymeropoulos
President, Chief Executive Officer and Chairman of the Board
Andrew Tsai
Analyst, Jefferies
Madison El-Sadi
Analyst, B. Riley Securities
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Vanda Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.051 -- 00:00:05.933 Good afternoon and welcome to the second quarter 2026 Vanda Pharmaceuticals 00:00:05.933 -- 00:00:07.333 Inc. 00:00:07.333 -- 00:00:12.495 earnings conference call. I am Franz and I'll be the operator assisting 00:00:12.495 -- 00:00:17.717 you today. All lines have been placed on mute to prevent any background noise. 00:00:17.717 -- 00:00:22.098 After the speaker's remarks, there will be a question and answer session. 00:00:22.098 -- 00:00:27.560 If you would like to ask a question during this time, simply press star 1 on your telephone 00:00:27.560 -- 00:00:33.341 keypad. If you would like to withdraw your question, please press star 1 again. 00:00:33.341 -- 00:00:38.564 Thank you. I would now like to turn the call over to Vandes Chief 00:00:38.564 -- 00:00:43.768 Financial Officer, Kevin Moran. Please go ahead. 00:00:43.768 -- 00:00:48.091 Thank you, France. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals' 00:00:48.091 -- 00:00:53.094 second quarter 2026 performance. Our second quarter 2026 results were 00:00:53.094 -- 00:00:58.307 released this afternoon and are available on the SEC's EDGAR system and on our website. 00:00:58.307 -- 00:01:00.307 www.vandapharma.com. 00:01:01.548 -- 00:01:05.530 In addition, we are providing live and archived versions of this conference call on our 00:01:05.530 -- 00:01:06.970 website. 00:01:06.970 -- 00:01:11.352 Joining me on today's call is Dr. Mihael Polymeropoulos, our President, Chief Executive 00:01:11.352 -- 00:01:16.274 Officer, and Chairman of the Board, and Daniel McGuire, our General Counsel. 00:01:16.274 -- 00:01:20.416 Following my introductory remarks, Mihael will update you on our ongoing activities. 00:01:20.416 -- 00:01:25.337 I will then comment on...